SANA : Interim Report Q1 2024 - MarketScreener : vimarsana.c

INTERIM REPORT FOR SANIONA AB 556962-5345 January - March 2024


Published May 29, 2024


Advancing our epilepsy assets and driving innovation...

Related Keywords

Stockholm , Sweden , Mexico , Copenhagen , Køavn , Denmark , Boehringer Ingelheim Gmb , Formue Nord , Thomas Feldthus , Productos Medix , Boehringer Ingelheim , Boehringer Ingelheim Gmbh , Astronautx Limited , Nasdaq Stockholm Main , Positive Allosteric Modulator , Genetic Absence Epilepsy Rat , Trigeminal Neuralgia , Positron Emission Tomography ,